Kiah M. Williams

Kiah M. Williams

Auto-generated profile, based on publicly available information

Kiah M. Williams

Department of Cardiothoracic Surgery, Stanford University School of Medicine , Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2019 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
LSLyndsay M. Stapleton
Lyndsay M. Stapleton
ASAmanda N. Steele
Amanda N. Steele
HWHanjay Wang
Hanjay Wang
HHHector Lopez Hernandez
Hector Lopez Hernandez
AYAnthony C. Yu
Anthony C. Yu
YWY. Joseph Woo
Y. Joseph Woo

31 May 2020 in Microbial Biotechnology
Verified
Journal Article
Open access
PDF file
KWKiah M. Williams
Kiah M. Williams
HWHanjay Wang
Hanjay Wang
MPMichael J. Paulsen
Michael J. Paulsen
ATAkshara D. Thakore
Akshara D. Thakore
MRMary Rieck
Mary Rieck
YWY. Joseph Woo
Y. Joseph Woo
Summary: The cyanobacterium Synechococcus elongatus (SE) has been shown to rescue ischaemic heart muscle after myocardial infarction by photosynthetic oxygen production. Here, we investigated SE toxicity and hypothesized that systemic SE exposure does not elicit a significant immune response in rats. Wistar rats intravenously received SE ( n = 12), sterile saline ( n = 12) or E. coli lipopolysaccharide (LPS, n = 4), and a subset (8 SE, 8 saline) received a repeat injection 4 weeks later. At baseline, 4 h, 24 h, 48 h, 8 days and 4 weeks after injection, clinical assessments, blood cultures, blood counts, lymphocyte phenotypes, liver function tests, proinflammatory cytokines and immunoglobulins were assessed. Across all metrics, SE rats responded comparably to saline controls, displaying no clinically significant immune response. As expected, LPS rats exhibited severe immunological responses. Systemic SE administration does not induce sepsis or toxicity in rats, thereby supporting the safety of cyanobacteria–mammalian symbiotic therapeutics using this organism.

1 August 2021 in European Heart Journal
Verified
Journal Article
Closed access
YZYuanjia Zhu
Yuanjia Zhu
BLBharathi Lingala
Bharathi Lingala
MBMichael Baiocchi
Michael Baiocchi
VAVeronica Toro Arana
Veronica Toro Arana
KWKiah M Williams
Kiah M Williams
YWY. Joseph Woo
Y. Joseph Woo
Aims : Since 1968, heart transplantation has become the definitive treatment for patients with end-stage heart failure. We aimed to summarize our experience in heart transplantation at Stanford University since the first transplantation performed over 50 years ago. Methods and results : From 6 January 1968 to 30 November 2020, 2671 patients presented to Stanford University for heart transplantation, of which 1958 were adult heart transplantations. Descriptive analyses were performed for patients in 1968–95 (n = 639). Stabilized inverse probability weighting was applied to compare patients in 1996–2006 (n = 356) vs. 2007–19 (n = 515). Follow-up data were updated through 2020. The primary endpoint was all-cause mortality. Prior to weighting, recipients in 2007–19 vs. those in 1996–2006 were older and had heavier burden of chronic diseases. After the application of stabilized inverse probability weighting, the distance organ travelled increased from 84.2 ± 111.1 miles to 159.3 ± 169.9 miles from 1996–2006 to 2007–19. Total allograft ischaemia time also increased over time (199.6 ± 52.7 vs. 225.3 ± 50.0 min). Patients in 2007–19 showed superior survival than those in 1996–2006 with a median survival of 12.1 vs. 11.1 years. Conclusion : In this half-century retrospective descriptive study from one of the largest heart transplant programmes in the USA, long-term survival after heart transplantation has improved over time despite increased recipient and donor age, worsening comorbidities, increased technical complexity, and prolonged total allograft ischaemia time. Further investigation is warranted to delineate factors associated with the excellent outcomes observed in this study.

1 August 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
SBSimar S. Bajaj
Simar S. Bajaj
HWHanjay Wang
Hanjay Wang
KWKiah M. Williams
Kiah M. Williams
JPJoshua M. Pickering
Joshua M. Pickering
JHJoseph C. Heiler
Joseph C. Heiler
JBJack H. Boyd
Jack H. Boyd

17 March 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
HWHanjay Wang
Hanjay Wang
SBSimar S. Bajaj
Simar S. Bajaj
KWKiah M. Williams
Kiah M. Williams
COChristian T. O'DOnnell
Christian T. O'DOnnell
JHJoseph C. Heiler
Joseph C. Heiler
JBJack H. Boyd
Jack H. Boyd

1 February 2022 in Surgery
Verified
Journal Article
Closed access
SBSimar S. Bajaj
Simar S. Bajaj
HWHanjay Wang
Hanjay Wang
KWKiah M. Williams
Kiah M. Williams
AKAravind Krishnan
Aravind Krishnan
JHJoseph C. Heiler
Joseph C. Heiler
JBJack H. Boyd
Jack H. Boyd